SF0426OA6643/072026
13/07/2028
Active ingredient:
Ondansetron 4 mg.
Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).
Dosage form
Solution for injection.
Active ingredient:Omeprazole 40 mg. Therapeutic indications:Indicated for treatment of...
Read More Active ingredient:Ondansetron 4 mg. Therapeutic indications:Indicated for the management...
Read More
Active ingredient:Ondansetron 8 mg. Therapeutic indications:Indicated for the management...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
